Skip to main content
Figure 1 | BMC Urology

Figure 1

From: Panobinostat synergizes with bortezomib to induce endoplasmic reticulum stress and ubiquitinated protein accumulation in renal cancer cells

Figure 1

The combination of panobinostat and bortezomib inhibited renal cancer growth effectively. A, MTS assay results (mean ± SD, n = 6) after cells were treated for 48 hours either with bortezomib or panobinostat alone or with bortezomib and panobinostat together. B, Colony formation assay results (mean ± SD, n = 3) after 1–2 week incubation in control media (C) or media containing 50 nM panobinostat (P) and/or 10 nM bortezomib (B). *p = 0.0495; **p = 0.0463.

Back to article page